SCHEMBL17669103

SCHEMBL17669103

CCCCCC(Cl)C[SiH](OCC)OCC

nearest known ligand 0.37

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 1/20 0.37
TP53 P04637 1/20 0.34
LMNA P02545 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17669056 0.94 DNM1 (0.30)
SCHEMBL17669038 0.85
SCHEMBL17669049 0.82 OPRM1 (0.33) OPRM1TP53LMNA
SCHEMBL557150 0.76
SCHEMBL17668937 0.75 CA1 (0.31)
SCHEMBL19511682 0.74 OPRM1 (0.35) OPRM1LMNA
SCHEMBL28891706 0.74 OPRM1 (0.35) OPRM1LMNA
SCHEMBL20495663 0.74 TP53 (0.31) TP53
SCHEMBL31606848 0.73 OPRM1 (0.34) OPRM1TP53LMNA
SCHEMBL5574677 0.72 LMNA (0.38) OPRM1TP53LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3009439-B1 CYCLIC AMINOORGANOXYSILANE COMPOUND AND ITS PRODUCTION METHOD SHINETSU CHEMICAL CO (JP) 2018-01-03 EP disclosed
US-9371341-B2 Cyclic aminoorganoxysilane compound and its production method SHIN-ETSU CHEMICAL CO., LTD. (JP) 2016-06-21 US disclosed
EP-3009439-A1 CYCLIC AMINOORGANOXYSILANE COMPOUND AND ITS PRODUCTION METHOD Shin-Etsu Chemical Co., Ltd. (JP) 2016-04-20 EP disclosed
US-20160102111-A1 CYCLIC AMINOORGANOXYSILANE COMPOUND AND ITS PRODUCTION METHOD SHIN-ETSU CHEMICAL CO., LTD. (JP) 2016-04-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160102111-A1 CYCLIC AMINOORGANOXYSILANE COMPOUND AND ITS PRODUCTION METHOD BCAT2, BCAT1, AKR1B10 OPRM1 323/4885TP53 4435/4885LMNA 3625/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.